New drug shows promise for Post-Surgery sugar crashes
Disease control
Completed
This study tested a drug called mizagliflozin in 15 people who had gastric bypass surgery and suffer from dangerously low blood sugar after eating. The goal was to see if the drug could reduce these episodes and improve safety. The trial is now complete, and results will help det…
Phase: PHASE2 • Sponsor: Vogenx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC